Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life

American Journal of Obstetrics and Gynecology

Volumn 216, Issue 5, 2017, Pages 523.e1-523.e7

  Bokslag, Anouk ^a   Teunissen, Pim W ^a,b   Franssen, Constantijn ^a,c   van Kesteren, Floortje ^a,d   Kamp, Otto ^a   Ganzevoort, Wessel ^d   Paulus, Walter J ^a   de Groot, Christianne J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cardiovascular disease; cardiovascular risk factors; early onset preeclampsia; metabolic syndrome; preeclampsia; prevention; women's health

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAMILY HISTORY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; OBSERVATIONAL STUDY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TERTIARY CARE CENTER; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; FOLLOW UP; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; WOMEN'S HEALTH;

ADULT; ALBUMINURIA; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH;

EID: 85015985816     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2017.02.015     Document Type: Article

References (25)

1. 1 Mol, B.W., Roberts, C.T., Thangaratinam, S., Magee, L.A., de Groot, C.J., Hofmeyr, G.J., Pre-eclampsia. Lancet 387 (2016), 999–1011.
2. 2 American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. 2013, American College of Obstetricians and Gynecologists, Washington, DC.
3. 3 Ahmed, R., Dunford, J., Mehran, R., Robson, S., Kunadian, V., Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 63 (2014), 1815–1822.
4. 4 McDonald, S.D., Malinowski, A., Zhou, Q., Yusuf, S., Devereaux, P.J., Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156 (2008), 918–930.
5. 5 Nichols, M., Townsend, N., Scarborough, P., Rayner, M., Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35 (2014), 2950–2959.
6. 6 Sattar, N., Greer, I.A., Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 325 (2002), 157–160.
7. 7 Zoet, G.A., Koster, M.P., Velthuis, B.K., et al. Determinants of future cardiovascular health in women with a history of preeclampsia. Maturitas 82 (2015), 153–161.
8. 8 Brown, M.A., Lindheimer, M.D., de, S.M., Van, A.A., Moutquin, J.M., The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20 (2001), IX–XIV.
9. 9 Okura, Y., Urban, L.H., Mahoney, D.W., Jacobsen, S.J., Rodeheffer, R.J., Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57 (2004), 1096–1103.
10. 10 Chobanian, A.V., Bakris, G.L., Black, H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003), 2560–2572.
11. 11 Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001), 2486–2497.
12. 12 Kloch-Badelek, M., Kuznetsova, T., Sakiewicz, W., et al. Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds. Cardiovasc Ultrasound, 10, 2012, 10.
13. 13 van Rijn, B.B., Nijdam, M.E., Bruinse, H.W., et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol 121 (2013), 1040–1048.
14. 14 Manten, G.T., Sikkema, M.J., Voorbij, H.A., Visser, G.H., Bruinse, H.W., Franx, A., Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 26 (2007), 39–50.
15. 15 Drost, J.T., Arpaci, G., Ottervanger, J.P., et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). Eur J Prev Cardiol 19 (2012), 1138–1144.
16. 16 Blokstra, A., Vissink, P., Venmans, L.M.A.J., et al. Nederland de Maat Genomen, 2009-2010. Monitoring van risicofactoren in de algemene bevolking. 2011, RIVM, Bilthoven.
17. 17 Heida, K.Y., Franx, A., van Rijn, B.B., et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension 66 (2015), 1116–1122.
18. 18 Heida, K.Y., Bots, M.L., de Groot, C.J., et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline. Eur J Prev Cardiol 23 (2016), 1863–1879.
19. 19 Perk, J., De Backer, G., Gohlke, H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33 (2012), 1635–1701.
20. 20 Mosca, L., Benjamin, E.J., Berra, K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 57 (2011), 1404–1423.
21. 21 Hermes, W., Franx, A., van Pampus, M.G., et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol 208 (2013), 474–478.
22. 22 Veerbeek, J.H., Hermes, W., Breimer, A.Y., et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 65 (2015), 600–606.
23. 23 James, P.A., Oparil, S., Carter, B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
24. 24 Blood Pressure Lowering Treatment Trialists Collaboration, Turnbull, F., Neal, B., Ninomiva, T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336 (2008), 1121–1123.
25. 25 Berks, D., Hoedjes, M., Raat, H., Duvekot, J.J., Steegers, E.A., Habbema, J.D., Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study. BJOG 120 (2013), 924–931.